LIPELLA PHARMACEUTICALS INC. Research And Development Expense

Quick Answer

LIPELLA PHARMACEUTICALS INC. reported Research And Development Expense of $3.61 million for the year ending 2024.

  • LIPELLA PHARMACEUTICALS INC. showed an increase of +18.9% in Research And Development Expense from 2023 to 2024.
  • This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), LIPELLA PHARMACEUTICALS INC.'s Research And Development Expense has grown by 148.0%.
  • Historical annual values: Fiscal year 2024: $3.61 million | Fiscal year 2023: $3.04 million | Fiscal year 2022: $2.55 million | Fiscal year 2021: $1.46 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: